CRP and triple-A syndrome: Outcome measures were grouped into aneurysm expansion rate, the number of patients who had AAA rupture or repair, C. pneumoniae antibody titers, and serum concentration of C-reactive protein (CRP). The results of this study suggest that the overall aneurysm expansion rates during the last two six-month periods were significantly lower in the doxycycline group than in the placebo group.